Transaction · 0002124509-26-000012

Mancini Anthony

Mancini Anthony, SR, reported a transaction classified as exercise at Revolution Medicines, Inc. involving 3121.000000 shares for an estimated $0.00. Reported holdings after the transaction were 93625.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MSR
RVMDRevolution Medicines, Inc.
Filing timeSep 28
Trade dateSep 25, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$201.74
Pre-filing
1mo ago +5.8%1w ago -5.3%1d ago -0.9%
Returns since
7d30d90d180d1y

RVMD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RVMD since 2026-09-28Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0002124509-26-000012
Stock Option (Right to Buy)
Transaction date
Sep 25, 2026
Filed Sep 28, 2026, 10:00 PM · 3d delay
Shares
3.12k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
93.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership 10b5-1 Detected
-20score
Filing-only score

-20

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.

  2. F2

    Includes 39,575 restricted stock units.

  3. F3

    Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the…

Original filing · 0002124509-26-000012
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RVMD